Autret A, Minz M, Beillevaire T, Degos C, Cathala H P
Biomedicine. 1977 Jul;27(5):200-3.
d.1 5 hydroxy-trytophan (600 mg a day) or a placebo were administered during 4 weeks following a double blind cross over design to 11 narcoleptic-cataplectic patients. Daily number of cataplectic and narcoleptic attacks did not vary. The 36 hours polygraphic recordings performed at the end of each treatment exhibit: a trend toward a decrease of the duration of the day time sleep and a significant increase of the duration of the night sleep.
d.1 按照双盲交叉设计，对11名发作性睡病-猝倒症患者在4周内给予5-羟色氨酸（每日600毫克）或安慰剂。每日猝倒发作次数和发作性睡病发作次数没有变化。在每种治疗结束时进行的36小时多导睡眠图记录显示：白天睡眠时间有缩短趋势，夜间睡眠时间显著增加。
